Privately-held US biotech Georgiamune has announced the appointment of Mark Avagliano (pictured, above) as chief business ...

VBI Vaccines is recalling PreHevbrio and shutting down operations amid bankruptcy. Despite FDA approval in 2021, the ...

New York-based Mind Medicine, a company developing MM120, a form of LSD (lysergide d-tartrate), for mental health conditions, ...

Lindis Biotech has licensed Korjuny (catumaxomab) to Pharmanovia for malignant ascites, offering a targeted immune therapy ...

Cellular immunotherapy specialist Fate Therapeutics soared as much as 73%, and closed up 12.45 at $2.27 yesterday, after it ...

UK pharma major GSK today announced positive headline results of GLISTEN, the ongoing global Phase III clinical trial ...

Australia’s CSL Behring (ASX: CSL) plans to shut down its Californian R&D facility focused on cell and gene therapies by ...

Californian oncology-focused biotech Avenzo Therapeutics has announced a pair of important updates.

AbbVie says that Elahere is the first and only folate receptor alpha (FRɑ)-directed antibody drug conjugate (ADC) medicine ...

UK clinical-stage gene specialist Silence Therapeutics (Nasdaq: SLN) yesterday presented end-of-treatment data from its Phase ...

Swiss cancer giant Novartis (NOVN: VX) has entered into an exclusive worldwide licensing and collaboration deal with Ratio ...

New York-based ophthalmic technology company Eyenovia is considering its options. Shares in the company dropped by 70% on ...